SE528407C2 - Borföreningar användbara vid BNCT - Google Patents

Borföreningar användbara vid BNCT

Info

Publication number
SE528407C2
SE528407C2 SE0501903A SE0501903A SE528407C2 SE 528407 C2 SE528407 C2 SE 528407C2 SE 0501903 A SE0501903 A SE 0501903A SE 0501903 A SE0501903 A SE 0501903A SE 528407 C2 SE528407 C2 SE 528407C2
Authority
SE
Sweden
Prior art keywords
tumor
compound
formula
boron
therapy
Prior art date
Application number
SE0501903A
Other languages
English (en)
Swedish (sv)
Other versions
SE0501903L (sv
Inventor
Lars-Inge Olsson
Arne Eek
Erwan Arzel
Original Assignee
Hammercap Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hammercap Ab filed Critical Hammercap Ab
Priority to SE0501903A priority Critical patent/SE528407C2/sv
Priority to PCT/SE2006/000952 priority patent/WO2007021234A1/en
Priority to RU2008110472/04A priority patent/RU2423368C2/ru
Priority to US11/990,634 priority patent/US8183247B2/en
Priority to JP2008526905A priority patent/JP5053277B2/ja
Priority to EP06769619.5A priority patent/EP1915381B1/en
Priority to CN2006800301784A priority patent/CN101268085B/zh
Priority to TW095130337A priority patent/TWI376381B/zh
Publication of SE0501903L publication Critical patent/SE0501903L/xx
Publication of SE528407C2 publication Critical patent/SE528407C2/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/027Organoboranes and organoborohydrides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
SE0501903A 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT SE528407C2 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0501903A SE528407C2 (sv) 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT
PCT/SE2006/000952 WO2007021234A1 (en) 2005-08-19 2006-08-17 Boron compounds useful in bnct
RU2008110472/04A RU2423368C2 (ru) 2005-08-19 2006-08-17 Соединения бора, пригодные при борнейтронозахватной терапии
US11/990,634 US8183247B2 (en) 2005-08-19 2006-08-17 Boron compounds useful in BNCT
JP2008526905A JP5053277B2 (ja) 2005-08-19 2006-08-17 Bnctに有用なホウ素化合物
EP06769619.5A EP1915381B1 (en) 2005-08-19 2006-08-17 Boron compounds useful in bnct
CN2006800301784A CN101268085B (zh) 2005-08-19 2006-08-17 用于硼中子俘获治疗的硼化合物
TW095130337A TWI376381B (en) 2005-08-19 2006-08-18 Boron compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0501847 2005-08-19
SE0501903A SE528407C2 (sv) 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT

Publications (2)

Publication Number Publication Date
SE0501903L SE0501903L (sv) 2006-11-07
SE528407C2 true SE528407C2 (sv) 2006-11-07

Family

ID=37310298

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0501903A SE528407C2 (sv) 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT

Country Status (8)

Country Link
US (1) US8183247B2 (https=)
EP (1) EP1915381B1 (https=)
JP (1) JP5053277B2 (https=)
CN (1) CN101268085B (https=)
RU (1) RU2423368C2 (https=)
SE (1) SE528407C2 (https=)
TW (1) TWI376381B (https=)
WO (1) WO2007021234A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007026701A1 (de) * 2007-06-01 2008-12-04 Universität Leipzig Neue chemische Verbindungen, deren Herstellung und deren Verwendung
CN101713740B (zh) * 2009-12-31 2012-05-02 中国原子能科学研究院 分光光度测量生物样品中bnct药物里硼含量的方法
CN104151339B (zh) * 2013-05-17 2017-05-03 中国科学院近代物理研究所 含硼吖啶衍生物、其制备方法和应用
JP6360113B2 (ja) * 2016-07-28 2018-07-18 ステラファーマ株式会社 ホウ素含有化合物
KR101903693B1 (ko) * 2016-11-28 2018-10-04 가천대학교 산학협력단 BSH 합성을 위한 티오피롤리딘을 이용한 Na2[B12H12] 반응
JP7154528B2 (ja) * 2017-08-25 2022-10-18 国立大学法人東京工業大学 ホウ素含有葉酸誘導体
WO2020180390A1 (en) * 2019-03-04 2020-09-10 TAE Life Sciences Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof
CN112358494B (zh) * 2020-04-09 2021-09-28 南京大学 一种基于吖啶的碳硼烷衍生物及其在生物显影中的应用
CN112442095B (zh) * 2020-12-01 2022-07-22 上海科黛生物科技有限公司 一种维生素b12的精制方法及所得产品的应用
CN112979686B (zh) * 2021-02-08 2022-04-08 北京大学 一种新型硼携带剂、制备方法及其药物制剂
CN116874515B (zh) * 2023-05-10 2025-03-14 重庆高硼生物科技有限公司 一种氨基酸-bsh靶向杂合体化合物及其制备方法和应用
WO2025165163A1 (ko) * 2024-01-31 2025-08-07 (주)클리켐바이오 붕소중성자포획치료용 알부민 나노플랫폼 및 이를 포함하는 붕소중성자포획치료용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272250A (en) 1992-07-10 1993-12-21 Spielvogel Bernard F Boronated phosphoramidate compounds
US6180766B1 (en) 1993-12-02 2001-01-30 Raymond F. Schinazi Nucleosides and oligonucleotides containing boron clusters
CN1124821A (zh) * 1994-02-14 1996-06-19 肖冠英 同步齿带半潜传动全贯流水电机组
US5630786A (en) * 1994-06-27 1997-05-20 Ionix Corporation Boron neutron capture enhancement of fast neutron therapy
JP2685128B2 (ja) * 1995-07-21 1997-12-03 東北大学長 カルボラン含有ガドリニウム−dtpa錯体、その中間体、およびこれらの製造方法
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
DE19905094C1 (de) 1999-02-01 2000-10-12 Schering Ag Gadolinium (III)-Komplexe sowie ihre Verwendung für Zweischritt Strahlentherapieformen und diese enthaltende pharmazeutische Mittel
JP2001233883A (ja) * 2000-02-22 2001-08-28 Okayama Pref Gov Shin Gijutsu Shinko Zaidan カゴ状ホウ素化合物担持ポルフィリン錯体
EP1364954A4 (en) 2001-02-09 2009-10-28 Hiroyuki Kagechika Dicarba closo DODECARBORANDERIVATE
CA2555597C (en) * 2004-02-13 2016-06-14 The University Of British Columbia Radiolabeled compounds and compositions, their precursors and methods for their production
JP2005343858A (ja) * 2004-06-07 2005-12-15 Mebiopharm Co Ltd ホウ素イオンクラスター脂質及びこれを用いたリポソーム
JP2006096870A (ja) * 2004-09-29 2006-04-13 Stella Chemifa Corp ホウ素含有化合物

Also Published As

Publication number Publication date
JP2009504732A (ja) 2009-02-05
CN101268085A (zh) 2008-09-17
TWI376381B (en) 2012-11-11
RU2008110472A (ru) 2009-09-27
JP5053277B2 (ja) 2012-10-17
EP1915381B1 (en) 2013-04-10
US20090227539A1 (en) 2009-09-10
EP1915381A1 (en) 2008-04-30
EP1915381A4 (en) 2011-02-09
SE0501903L (sv) 2006-11-07
CN101268085B (zh) 2012-06-20
RU2423368C2 (ru) 2011-07-10
US8183247B2 (en) 2012-05-22
WO2007021234A1 (en) 2007-02-22
TW200740833A (en) 2007-11-01

Similar Documents

Publication Publication Date Title
EP2825528B1 (en) Substituted pyrrolidine-2-carboxamides
EP4365178A1 (en) Nitrogen-containing heterocyclic compound, and preparation method therefor, intermediate thereof, and application thereof
US10160759B2 (en) Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor
EP2793901A1 (en) Tricyclic boron compounds for antimicrobial therapy
SE528407C2 (sv) Borföreningar användbara vid BNCT
EP3964518A1 (en) Cd73 inhibitor, preparation method therefor and application thereof
EP3626241A1 (en) N-benzenesulfonylbenzamide compound for inhibiting bcl-2 protein and composition and use thereof
EP2857402A1 (en) Pyrrole [2, 1-f][1, 2, 4]triazine derivative and antitumor effect thereof
CN116143842A (zh) 氧化异阿朴菲生物碱与n-杂环卡宾的环金属铱配合物及其合成方法和应用
CN101638389B (zh) 一种含萘酰亚胺结构的多胺衍生物及其制备方法和应用
CN121652220A (zh) 含有三氟甲磺酰基的化合物
EP2119720A1 (en) Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives
KR102833011B1 (ko) 푸로[3,4-b]피롤-함유 BTK 억제제
CN113416189B (zh) 一类β-卡波林氮芥衍生物、制备方法和抗肿瘤用途
EP4261211A1 (en) Dihydroisoquinolinone derivative and application thereof
EP4144731B1 (en) Compounds containing benzosultam
CN116023417A (zh) 氧化异阿朴菲生物碱的n-杂环卡宾型环金属钌配合物及其合成方法和应用
CN108129483A (zh) 一种btk抑制剂及其应用
CN102775457B (zh) 核苷连萘二酰亚胺衍生物及其合成方法和用途
CN106928224A (zh) 吲哚类槐定碱衍生物及其制备方法
WO2026026904A1 (en) The crystalline forms of a compound
CN119978009B (zh) 一种色瑞替尼衍生物、其制备方法、应用及药物
HK40078957B (zh) 含苯基并内磺酰胺的化合物
CN116120254A (zh) 13,14-双一氧化氮供体-β-榄香烯衍生物及其制备和应用
CN118878530A (zh) 一种no供体配糖体及其制备方法与应用

Legal Events

Date Code Title Description
NUG Patent has lapsed